Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

282 trials

NCT05835310
Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Phase 3 · Argentina, Brazil, Canada, China, Colombia, Germany, Spain, France, United Kingdom, Italy, Japan, Mexico, Poland, Portugal, United States, South Africa · 93 sites
Registry update: 30 Sept 2026
NCT06032923
Recruiting
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
Phase 1/2 · United States · 1 site
Registry update: 31 Jul 2026
NCT06285279
Recruiting
The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
Phase 1 · China · 1 site
Registry update: 6 Jul 2026
NCT06121297
Recruiting
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Phase 1/2 · Canada, Spain, France, United States · 28 sites
Registry update: 6 Oct 2026
NCT06277427
Recruiting
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
Not applicable · China · 1 site
Registry update: 26 Feb 2024
NCT07700940
Recruiting
The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population
Phase 4 · Egypt · 1 site
Registry update: 15 Jul 2026
NCT06106893
Recruiting
A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
Phase 1/2 · China · 1 site
Registry update: 8 Jan 2025
NCT06593041
Recruiting
ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
Not applicable · France · 1 site
Registry update: 19 Sept 2024
NCT06406205
Recruiting
A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis
Phase 3 · China · 10 sites
Registry update: 9 May 2024
NCT05559671
Recruiting
Safety of the Herpes Zoster Subunit Vaccine in Lupus
Phase 4 · United States · 2 sites
Registry update: 28 Oct 2026
NCT05714930
Recruiting
LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus
Not applicable · Germany · 14 sites
Registry update: 17 Jun 2026
NCT05440422
Recruiting
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
Phase 2 · United States · 1 site
Registry update: 18 Sept 2026
NCT06167174
Recruiting
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
Not applicable · China · 1 site
Registry update: 12 Dec 2023
NCT06462768
Recruiting
Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
Not applicable · France · 1 site
Registry update: 17 Jun 2024
NCT05698173
Recruiting
Systemic Lupus Erythematosus and Accelerated Aging
Not applicable · France · 1 site
Registry update: 4 Sept 2025
NCT06010472
Recruiting
An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus
Early phase 1 · China · 1 site
Registry update: 29 Apr 2025
NCT06058078
Recruiting
RY_SW01 Cell Injection Therapy in Active Lupus Nephritis
Phase 2 · China · 1 site
Registry update: 18 Jan 2024
NCT05859191
Recruiting
Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus
Not applicable · France · 1 site
Registry update: 30 Apr 2026
NCT05927688
Recruiting
Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
Not applicable · France · 1 site
Registry update: 12 Mar 2025
NCT06347718
Recruiting
CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
Phase 1/2 · Germany · 1 site
Registry update: 30 Sept 2025

Ordered by registry start date. Freshness and sponsorship never change the order.